LSTM Home > LSTM Research > LSTM Online Archive

Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe

Mwenge, Lawrence, Sande, Linda, Mangenah, Collin, Ahmed, Nurilign, Kanema, Sarah, d’Elbée, Marc, Sibanda, Euphemia ORCID:, Kalua, Thokozani, Ncube, Gertrude, Johnson, Cheryl C., Hatzold, Karin, Cowan, Frances ORCID:, Corbett, Elizabeth L., Ayles, Helen, Maheswaran, Hendramoorthy and Terris-Prestholt, Fern (2017) 'Costs of facility-based HIV testing in Malawi, Zambia and Zimbabwe'. PLoS ONE, Vol 12, Issue 10, e0185740.

pone.0185740_HIV.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
Official URL:


Background Providing HIV testing at health facilities remains the most common approach to ensuring access to HIV treatment and prevention services for the millions of undiagnosed HIV-infected individuals in sub-Saharan Africa. We sought to explore the costs of providing these services across three southern African countries with high HIV burden. Methods Primary costing studies were undertaken in 54 health facilities providing HIV testing services (HTS) in Malawi, Zambia and Zimbabwe. Routinely collected monitoring and evaluation data for the health facilities were extracted to estimate the costs per individual tested and costs per HIV-positive individual identified. Costs are presented in 2016 US dollars. Sensitivity analysis explored key drivers of costs. Results Health facilities were testing on average 2290 individuals annually, albeit with wide variations. The mean cost per individual tested was US$5.03.9 in Malawi, US$4.24 in Zambia and US$8.79 in Zimbabwe. The mean cost per HIV-positive individual identified was US$79.58, US$73.63 and US$178.92 in Malawi, Zambia and Zimbabwe respectively. Both cost estimates were sensitive to scale of testing, facility staffing levels and the costs of HIV test kits. Conclusions Health facility based HIV testing remains an essential service to meet HIV universal access goals. The low costs and potential for economies of scale suggests an opportunity for further scale-up. However low uptake in many settings suggests that demand creation or alternative testing models may be needed to achieve economies of scale and reach populations less willing to attend facility based services.

Item Type: Article
Subjects: W General Medicine. Health Professions > W 74 Medical economics. Health care costs
WA Public Health > WA 30 Socioeconomic factors in public health (General)
WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503 Acquired immunodeficiency syndrome. HIV infections
WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.1 Diagnosis
Faculty: Department: Clinical Sciences & International Health > International Public Health Department
Clinical Sciences & International Health > Malawi-Liverpool-Wellcome Programme (MLW)
Digital Object Identifer (DOI):
Depositing User: Stacy Murtagh
Date Deposited: 18 Oct 2017 11:37
Last Modified: 07 Oct 2019 07:36


View details

Actions (login required)

Edit Item Edit Item